Urging the Supreme Court to Uphold Access to PrEP for HIV Prevention

I am writing to urge you to uphold the law requiring drugs like Pre-Exposure Prophylaxis (PrEP) to be included as preventative medicine under the Affordable Care Act. PrEP has proven to be a highly effective tool in the fight against HIV, significantly reducing the risk of transmission when taken as prescribed. This medication has been a game-changer in public health, offering hope and protection to millions of individuals at risk of HIV infection. The effectiveness of PrEP in preventing HIV cannot be overstated. Studies have shown that PrEP reduces the risk of contracting HIV by up to 99% when taken consistently. This remarkable efficacy has made PrEP an essential component of comprehensive HIV prevention strategies, contributing to the decline in new HIV infections in communities where it is widely accessible. Furthermore, it is crucial to recognize that the stigmatization of medical treatments, such as PrEP, has no place in our society. Efforts to portray these treatments as bad or wrong only serve to undermine public health initiatives and perpetuate harmful stereotypes. Stigmatization not only discourages individuals from seeking necessary medical care but also exacerbates the spread of HIV by creating barriers to prevention. It is also important to highlight the rise in HIV cases among heterosexual individuals, which can be attributed, in part, to the stigmatization of taking preventative medicine responsibly. By ensuring that PrEP remains accessible and covered under preventative care, we can address this growing public health concern and work towards reducing HIV transmission across all demographics. In conclusion, I respectfully urge the Supreme Court to uphold the law requiring PrEP to be included as preventative medicine. Doing so will affirm our commitment to public health, reduce the stigma associated with HIV prevention, and ultimately save lives.